Severe acute kidney injury following major liver resection without portal clamping: incidence, risk factors, and impact on short-term outcomes

HPB (Oxford). 2018 Sep;20(9):865-871. doi: 10.1016/j.hpb.2018.03.011.

Abstract

Background: Acute kidney injury (AKI) following major hepatectomy (MH) remains inadequately investigated. This retrospective study aimed to assess the risk factors and prognostic value of AKI on short-term outcomes following MH without portal pedicle clamping.

Methods: From January 2014 through June 2017, 111 consecutive patients underwent MH without portal pedicle clamping, but with intraoperative low-crystalloid infusion. Kidney Disease Improving Global Outcomes stages II and III were classified as severe AKI.

Results: A total of 102 patients did not develop AKI or only AKI stage I (92%, control group), whereas 9 patients developed severe AKI (8%, severe AKI group). Hepatectomy (P = 0.002) and surgery (P = 0.011) durations were longer in the severe AKI group. Clavien-Dindo grades 3 to 5 morbidity (55% versus 9%, P = 0.001), liver failure (P = 0.017), and 90-day mortality (33% versus 2%, P = 0.003) were significantly higher in the severe AKI group. After a multivariate analysis, the duration of hepatectomy (cut-off: 250 min; P = 0.029) and urea serum levels on postoperative day 3 (P = 0.006) were identified as independent predictors of severe AKI.

Discussion: Severe AKI, is common with increased duration of hepatectomy, was associated with poor short-term outcomes, and can be predicted by operative duration greater than 250 minutes.

Publication types

  • Observational Study

MeSH terms

  • Acute Kidney Injury / diagnosis
  • Acute Kidney Injury / epidemiology*
  • Acute Kidney Injury / mortality
  • Acute Kidney Injury / therapy
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Crystalloid Solutions / administration & dosage
  • Databases, Factual
  • Female
  • France / epidemiology
  • Hepatectomy / adverse effects*
  • Hepatectomy / mortality
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Operative Time
  • Retrospective Studies
  • Risk Factors
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome
  • Urea / blood

Substances

  • Biomarkers
  • Crystalloid Solutions
  • Urea